{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:54:03Z","timestamp":1784778843780,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijbiomac.2026.150821","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:23:56Z","timestamp":1770769436000},"page":"150821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural reprogramming of irradiated ellagic acid suppresses cell cycle regulators and modulates cytokines via activation of the p53\/BAX-CASP3\/Bcl-2-cyclin D1 pathway: Validation studies across breast cancer cell lines"],"prefix":"10.1016","volume":"349","author":[{"given":"Hager M.","family":"Eldairy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar Abd El-Razik","family":"Mosallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-4297","authenticated-orcid":false,"given":"Alaa","family":"Elmetwalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150821_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0010","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0015","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.biopha.2017.09.059","article-title":"A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer","volume":"95","author":"Shafei","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0025","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/molecules26041109","article-title":"Plant-derived anti-cancer compounds as new perspectives in drug discovery and alternative therapy","volume":"26","author":"Dehelean","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0035","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.3390\/ijms241310663","article-title":"Inhibition of cancer development by natural plant polyphenols: molecular mechanisms","volume":"24","author":"Lyubitelev","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2015.04.008","article-title":"Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection","volume":"97","author":"Garc\u00eda-Ni\u00f1o","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115132","article-title":"The multifaceted mechanisms of ellagic acid in the treatment of tumors: state-of-the-art","volume":"165","author":"Lu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0050","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/nu10111756","article-title":"Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid","volume":"10","author":"Ceci","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0055","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/bab.2288","article-title":"Ellagic acid as a potent anti-cancer drug: a comprehensive review on in vitro, in vivo, in silico, and drug delivery studies","volume":"69","author":"Mohammadinejad","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.837111","article-title":"Gamma radiation processed polymeric materials for high performance applications: a review","volume":"10","author":"Naikwadi","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2022.110013","article-title":"Ionizing radiation technology to improve the physicochemical and biological properties of natural compounds by molecular modification: a review","volume":"194","author":"Song","year":"2022","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cccn.2005.03.037","article-title":"Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid","volume":"359","author":"Bhosle","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0976500X241240634","article-title":"A review on pharmacological advancement of ellagic acid","volume":"15","author":"Golmei","year":"2024","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5194508","article-title":"Ellagic acid derived urolithins as modulators of oxidative stress","volume":"2020","author":"Djedjibegovic","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111724","article-title":"Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review","volume":"183","author":"Alfei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1874467211104020096","article-title":"Radiation induced non-targeted response: mechanism and potential clinical implications","volume":"4","author":"Hei","year":"2011","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s40487-024-00296-1","article-title":"Exploring the potential of Ellagic acid in gastrointestinal Cancer prevention: recent advances and future directions","volume":"12","author":"Chauhan","year":"2024","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9965916","article-title":"The involvement of the oxidative stress status in cancer pathology: a double view on the role of the antioxidants","volume":"2021","author":"Zahra","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0105","first-page":"1","article-title":"The role of reactive oxygen species and antioxidants in oxidative stress","volume":"1","author":"Ozougwu","year":"2016","journal-title":"Int. J. Res."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0110","article-title":"Oxidative stress and lipid peroxidation products in cancer progression and therapy","volume":"2012","author":"Barrera","year":"2012","journal-title":"Int. Sch. Res. Not."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2165\/11592590-000000000-00000","article-title":"Cellular redox pathways as a therapeutic target in the treatment of cancer","volume":"71","author":"Montero","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0120","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00432-017-2464-9","article-title":"ROS-modulated therapeutic approaches in cancer treatment","volume":"143","author":"Raza","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0130","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/cac2.12295","article-title":"Cytokine and chemokine induced inflammatory colorectal tumor microenvironment: emerging avenue for targeted therapy","volume":"42","author":"Bhat","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0135","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/ijms24044002","article-title":"Crosstalk of inflammatory cytokines within the breast tumor microenvironment","volume":"24","author":"Habanjar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656908","article-title":"The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment","volume":"12","author":"Laha","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1019247","article-title":"Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0150","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/biom13111653","article-title":"Ellagic acid and cancer hallmarks: insights from experimental evidence","volume":"13","author":"\u010ci\u017em\u00e1rikov\u00e1","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.mseb.2024.117711","article-title":"Synthesis and characterization of HfO2 nanoparticles for dosimetry applications","volume":"310","author":"Alshahrani","year":"2024","journal-title":"Mater. Sci. Eng. B"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/gels10060381","article-title":"A comprehensive review of radiation-induced hydrogels: synthesis, properties, and multidimensional applications","volume":"10","author":"Ahmed","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nanoso.2024.101170","article-title":"Surface topography and surface morphology of graphene nanocomposite by FESEM, EDX and AFM analysis","volume":"38","author":"Nandee","year":"2024","journal-title":"Nano-Struct. Nano-Objects"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0170","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.3390\/ma15082836","article-title":"Preparation, characterization, solubility, and antioxidant capacity of ellagic acid-urea complex","volume":"15","author":"Sakurai","year":"2022","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1515\/tsd-2024-2614","article-title":"Forced stability studies and estimation of encapsulated ellagic acid in nano-formulations using UV-spectroscopy","volume":"62","author":"Kumar","year":"2025","journal-title":"Tenside Surfactant Deterg."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/metabo12060479","article-title":"Serum metabolomics based on gc-ms reveals the antipyretic mechanism of ellagic acid in a rat model","volume":"12","author":"Xie","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0185","first-page":"1","article-title":"Gold nanoparticles mediate suppression of angiogenesis and breast cancer growth via MMP-9\/NF- B\/mTOR and PD-L1\/PD-1 signaling: integrative in vitro validation and network pharmacology insights","author":"Elmetwalli","year":"2024","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-025-02899-8","article-title":"Green-synthesized silver\u2013copper nanocomposites from Sargassum latifolium: antibacterial, anti-cancer, and in silico pharmacokinetic evaluation","volume":"42","author":"Elattar","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12032-023-02250-z","article-title":"Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR\/\u03b2-catenin and MMP-14 for nitrogen homeostasis and liver cancer","volume":"41","author":"Elmetwalli","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0200","first-page":"774","article-title":"Eco-friendly fabrication of metal nanoparticles with enhanced antimicrobial and anti-cancer properties","volume":"11","author":"Eldfrawy","year":"2024","journal-title":"J. Basic Environ. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0205","first-page":"1","article-title":"Pfdn1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy","author":"Alokda","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0210","doi-asserted-by":"crossref","first-page":"48988","DOI":"10.1021\/acsomega.3c08819","article-title":"Ellagic acid induces DNA damage and apoptosis in Cancer stem-like cells and overcomes cisplatin resistance","volume":"9","author":"Mandal","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0215","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acs.jafc.2c05720","article-title":"The nephroprotective effects of hibiscus sabdariffa leaf and ellagic acid in vitro and in vivo models of hyperuricemic nephropathy","volume":"71","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21608\/mjvh.2022.279331","article-title":"Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model","volume":"7","author":"Elmetwalli","year":"2022","journal-title":"Med. J. Viral Hepat."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0225","doi-asserted-by":"crossref","unstructured":"A. Elmetwalli, S.M. Hashish, M.G. Hassan, M.A. El-Magd, S.A. El-Naggar, A.M. Tolba, A.F. Salama, Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer, Naunyn Schmiedeberg's Arch. Pharmacol. (2023) 1\u201313.","DOI":"10.1007\/s00210-023-02511-8"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-023-04142-1","article-title":"Hepatocellular carcinoma cells: activity of amygdalin and Sorafenib in targeting AMPK\/mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death","volume":"23","author":"El-Sewedy","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1515\/pac-2020-0902","article-title":"Methods to evaluate the scavenging activity of antioxidants toward reactive oxygen and nitrogen species (IUPAC technical report)","volume":"94","author":"Apak","year":"2022","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0240","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1177\/09603271211040825","article-title":"Synergistic effects of sinapic acid and ellagic acid ameliorate streptozotocin-induced diabetic nephropathy by inhibiting apoptosis, DNA damage, and structural deterioration in rats","volume":"40","author":"F. Alt","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0245","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12884-024-06914-0","article-title":"Impact of vitamin D deficiency on immunological and metabolic responses in women with recurrent pregnancy loss: focus on VDBP\/HLA-G1\/CTLA-4\/ENTPD1\/adenosine-fetal-maternal conflict crosstalk","volume":"24","author":"Al Balawi","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40643-024-00822-z","article-title":"Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study","volume":"11","author":"Al Balawi","year":"2024","journal-title":"Bioresour. Bioprocess."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2025.126630","article-title":"Citrate-capped AuNPs-induced redox reprogramming modulates the TP53\u2013BAX\/BCL2\u2013CASP3 axis, reinforcing antioxidant defense and promoting apoptotic signaling in liver cancer","volume":"344","author":"Elmetwalli","year":"2026","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0260","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbrc.2022.12.069","article-title":"Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution","volume":"644","author":"Fatehi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-024-02330-8","article-title":"Probiotic-derived silver nanoparticles target mTOR\/MMP-9\/BCL-2\/dependent AMPK activation for hepatic cancer treatment","volume":"41","author":"Elmetwalli","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0270","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/01635581.2017.1339811","article-title":"Ellagic acid enhances apoptotic sensitivity of breast cancer cells to -radiation","volume":"69","author":"Ahire","year":"2017","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4048\/jbc.2009.12.2.85","article-title":"Ellagic acid shows different anti-proliferative effects between the MDA-MB-231 and MCF-7 human breast cancer cell lines","volume":"12","author":"Kim","year":"2009","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0280","doi-asserted-by":"crossref","DOI":"10.56808\/2673-060X.5560","article-title":"Antioxidant and chemotherapeutic synergy: Triphala enhances doxorubicin cytotoxicity in breast cancer cells and reduces toxicity in non-tumorigenic cells","volume":"69","author":"Charucharana","year":"2025","journal-title":"Chulalongkorn Med. J."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.31557\/APJCP.2022.23.1.363","article-title":"Newly synthesized punicalin and punicalagin nano-prototypes induce breast cancer cytotoxicity through ROS-mediated apoptosis","volume":"23","author":"Abd-Rabou","year":"2022","journal-title":"Asian Pacific J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0290","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/a-0633-9492","article-title":"A pharmacological update of ellagic acid","volume":"84","author":"R\u00edos","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0295","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejps.2017.09.012","article-title":"Enhanced anti-cancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma","volume":"109","author":"El-Ashmawy","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0300","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.3390\/molecules27144478","article-title":"Doxorubicin-based hybrid compounds as potential anti-cancer agents: a review","volume":"27","author":"Peter","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0305","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/1570159X19666210809103346","article-title":"Phytochemicals targeting oxidative stress, interconnected neuroinflammatory, and neuroapoptotic pathways following radiation","volume":"20","author":"Fakhri","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0310","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/ph16020274","article-title":"Phenolic acids-mediated regulation of molecular targets in ovarian cancer: current understanding and future perspectives","volume":"16","author":"Nazam","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/life11030222","article-title":"The multifaceted regulation of mitochondria in ferroptosis","volume":"11","author":"Wu","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070367","article-title":"Natural biomolecules and derivatives as anti-cancer immunomodulatory agents","volume":"13","author":"Bernitsa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0325","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/pharmaceutics14071327","article-title":"Palmitic acid-conjugated radiopharmaceutical for integrin v 3-targeted radionuclide therapy","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0330","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11010-014-2257-2","article-title":"Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT-15 colon adenocarcinoma cells","volume":"399","author":"Umesalma","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0335","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/metabo13070796","article-title":"Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells","volume":"13","author":"Zhao","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0340","doi-asserted-by":"crossref","first-page":"14043","DOI":"10.1038\/s41598-017-14211-4","article-title":"Radiosensitizing effect of ellagic acid on growth of hepatocellular carcinoma cells: an in vitro study","volume":"7","author":"Das","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0345","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.3892\/or.2013.2757","article-title":"Apoptotic markers in a prostate cancer cell line: effect of ellagic acid","volume":"30","author":"Vanella","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0350","first-page":"1262","article-title":"Ellagic acid induces apoptosis in TSGH8301 human bladder cancer cells through the endoplasmic reticulum stress and mitochondria dependent signaling pathways","volume":"29","author":"Ho","year":"2014","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0355","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jphotobiol.2016.02.032","article-title":"Review on the binding of anti-cancer drug doxorubicin with DNA and tRNA: structural models and antitumor activity","volume":"158","author":"Agudelo","year":"2016","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00689680","article-title":"Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells","volume":"31","author":"Watts","year":"1994","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11010-018-3310-3","article-title":"Ellagic acid in suppressing in vivo and in vitro oxidative stresses","volume":"448","author":"Zeb","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0370","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10799893.2017.1298129","article-title":"Natural polyphenolic inhibitors against the antiapoptotic BCL-2","volume":"37","author":"Verma","year":"2017","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0375","unstructured":"scholar@scholar.googleusercontent.com, (n.d.). https:\/\/scholar.googleusercontent.com\/scholar.enw?q=info:Hf4oMquT9FMJ:scholar.google.com\/&output=citation&scisdr=CgKA1WOvELL4idtv9Go:AAZF9b8AAAAAaBtp7GtYYSJ1gjyndNl4ARr2iEE&scisig=AAZF9b8AAAAAaBtp7DNY22fi4Qm_UtXP-RpMb2E&scisf=3&ct=citation&cd=-1&hl=ar."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0380","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0385","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2005.05.064","article-title":"Cyclin D1 in breast cancer pathogenesis","volume":"23","author":"Arnold","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0390","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/D4FO04715J","article-title":"Dietary polyphenols for tumor therapy: bioactivities, nano-therapeutic systems and delivery strategies","volume":"16","author":"Wang","year":"2025","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0395","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab912c","article-title":"Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers","volume":"31","author":"Ceci","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0400","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41401-020-0471-x","article-title":"Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets","volume":"42","author":"Fa","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0405","doi-asserted-by":"crossref","first-page":"46663","DOI":"10.18632\/oncotarget.16944","article-title":"Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0410","article-title":"Aberrant expression of cyclin D1 in cancer","volume":"4","author":"Inoue","year":"2015","journal-title":"Sign. Transduct. Insights"},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0415","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1002\/fsn3.3699","article-title":"A comprehensive review on Ellagic acid in breast cancer treatment: from cellular effects to molecular mechanisms of action","volume":"11","author":"Golmohammadi","year":"2023","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0420","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.3390\/ijms21103526","article-title":"Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6","volume":"21","author":"Yousuf","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0425","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.3390\/app10103353","article-title":"Formulation strategies to improve oral bioavailability of ellagic acid","volume":"10","author":"Zuccari","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0430","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ijbiomac.2018.08.138","article-title":"Effect of gamma irradiation on structure, physicochemical and immunomodulatory properties of Astragalus polysaccharides","volume":"120","author":"Ren","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.150821_bb0435","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.7314\/APJCP.2014.15.6.2405","article-title":"Plant extracts and plant-derived compounds: promising players in countermeasure strategy against radiological exposure: a review","volume":"15","author":"Kma","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026007476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026007476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:18:27Z","timestamp":1773638307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026007476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":87,"alternative-id":["S0141813026007476"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150821","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural reprogramming of irradiated ellagic acid suppresses cell cycle regulators and modulates cytokines via activation of the p53\/BAX-CASP3\/Bcl-2-cyclin D1 pathway: Validation studies across breast cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150821"}}